Abbonarsi

Endoscopy or surgery for malignant GI outlet obstruction? - 18/08/11

Doi : 10.1016/S0016-5107(04)02757-9 
Mario Del Piano, MD , Marco Ballarè, MD, Franco Montino, MD, Annalisa Todesco, MS, Marco Orsello, MD, Corrado Magnani, MD, Enrico Garello, MD
Current affiliations: Gastroenterology Unit, ASO “Maggiore della Carità,” Novara, Italy, Unit of Medical Statistics and Epidemiology, Department of Medical Sciences, University of Eastern Piedmont, Novara, Italy 

Reprint requests: Mario Del Piano, MD, Gastroenterology, ASO “Maggiore della Carità,” Corso Mazzini 18, 28100 Novara, Italy.

Novara, Italy

Abstract

Background

The treatment of gastroduodenal outflow obstruction (GOO) caused by malignant diseases represents a significant challenge. Open surgical gastrojejunostomy (GJ) has been the treatment of choice, but it has high morbidity and mortality rates. More recently, endoscopic placement of self-expanding metallic stents (SEMS) has been proposed and the results of small, preliminary studies are encouraging. This study compared technical and clinical success, morbidity, mortality, and hospital stay in patients undergoing endoscopic and surgical treatment of GOO.

Methods

Medical records of 60 consecutive patients with GOO seen between April 1997 and November 2002 were retrospectively reviewed. Because of extremely short life expectancy, 13 patients were treated by insertion of a double-lumen nasogastric-jejunal tube. The remaining 47 patients (28 men, 19 women; mean age 73.5 years, range 48-92 years) with unresectable pancreatic (33), gastric (7), metastatic lymph nodal (4), papillary (2), and biliary (1) tumors were treated by placement of a SEMS (24) or open surgical GJ (23).

Results

The technical success rates were similar, but clinical success was lower in the GJ group (92% vs. 56%, p=0.0067). The SEMS group had a shorter length of hospital stay (3.0 [1.4] days vs. 24.1 [10.3], p < 0.001). Thirty-day mortality was 30% in the GJ group, and 0% in the SEMS group (p=0.004). Morbidity was higher in the GJ compared with the SEMS group (61% vs. 17%, p=0.0021). Mean survival was longer in the SEMS group (96.1 [9.6] days vs. 70.2 [36.2] days, p=0.0165 for a single test of hypothesis; Bonferroni correction for a multiple testing removes this significance), consequently, out-of-hospital survival was longer for the SEMS group (93.2 [9.3] days vs. 46.0 [31.5] days, p < 0.001). None of the endoscopic procedures required the assistance of an anesthesiologist or the use of an operating room.

Conclusions

The results of this retrospective study suggest that SEMS insertion is better than surgical GJ for palliation of patients with GOO in terms of clinical success, morbidity, and mortality. Technical success rates were similar. SEMS placement should be proposed as the first-line treatment for relief of GOO. However, a randomized, comparative, prospective study of SEMS vs. laparoscopic GJ is needed.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Presented as an oral communication at the annual meeting of the American Society for Gastrointestinal Endoscopy, May 17-22, 2003, Orlando, Florida (Gastrointest Endosc 2003;57:AB80).


© 2005  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 61 - N° 3

P. 421-426 - marzo 2005 Ritorno al numero
Articolo precedente Articolo precedente
  • The utility of EUS-guided FNA in the diagnosis of metastatic breast cancer to the esophagus and the mediastinum
  • Jason M. Sobel, Rebecca Lai, Shawn Mallery, Michael J. Levy, Maurits J. Wiersema, Bruce D. Greenwald, Naresh T. Gunaratnam
| Articolo seguente Articolo seguente
  • Third-tier fellowship training: advantages and program selection
  • Michael L. Kochman

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.